Report Overview
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
This report provides a deep insight into the global Retinal Biologics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Retinal Biologics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Retinal Biologics market in any manner.
Global Retinal Biologics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Market Segmentation (by Type)
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Retinal Biologics Market
? Overview of the regional outlook of the Retinal Biologics Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Retinal Biologics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Retinal Biologics
1.2 Key Market Segments
1.2.1 Retinal Biologics Segment by Type
1.2.2 Retinal Biologics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Retinal Biologics Market Overview
2.1 Global Market Overview
2.1.1 Global Retinal Biologics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Retinal Biologics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Retinal Biologics Market Competitive Landscape
3.1 Global Retinal Biologics Sales by Manufacturers (2019-2024)
3.2 Global Retinal Biologics Revenue Market Share by Manufacturers (2019-2024)
3.3 Retinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Retinal Biologics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Retinal Biologics Sales Sites, Area Served, Product Type
3.6 Retinal Biologics Market Competitive Situation and Trends
3.6.1 Retinal Biologics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Retinal Biologics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Retinal Biologics Industry Chain Analysis
4.1 Retinal Biologics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Retinal Biologics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Retinal Biologics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Retinal Biologics Sales Market Share by Type (2019-2024)
6.3 Global Retinal Biologics Market Size Market Share by Type (2019-2024)
6.4 Global Retinal Biologics Price by Type (2019-2024)
7 Retinal Biologics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Retinal Biologics Market Sales by Application (2019-2024)
7.3 Global Retinal Biologics Market Size (M USD) by Application (2019-2024)
7.4 Global Retinal Biologics Sales Growth Rate by Application (2019-2024)
8 Retinal Biologics Market Segmentation by Region
8.1 Global Retinal Biologics Sales by Region
8.1.1 Global Retinal Biologics Sales by Region
8.1.2 Global Retinal Biologics Sales Market Share by Region
8.2 North America
8.2.1 North America Retinal Biologics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Retinal Biologics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Retinal Biologics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Retinal Biologics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Retinal Biologics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Spark Therapeutics, Inc
9.1.1 Spark Therapeutics, Inc Retinal Biologics Basic Information
9.1.2 Spark Therapeutics, Inc Retinal Biologics Product Overview
9.1.3 Spark Therapeutics, Inc Retinal Biologics Product Market Performance
9.1.4 Spark Therapeutics, Inc Business Overview
9.1.5 Spark Therapeutics, Inc Retinal Biologics SWOT Analysis
9.1.6 Spark Therapeutics, Inc Recent Developments
9.2 F. Hoffmann-La Roche Ltd
9.2.1 F. Hoffmann-La Roche Ltd Retinal Biologics Basic Information
9.2.2 F. Hoffmann-La Roche Ltd Retinal Biologics Product Overview
9.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd Business Overview
9.2.5 F. Hoffmann-La Roche Ltd Retinal Biologics SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd Recent Developments
9.3 Regeneron Pharmaceuticals, Inc
9.3.1 Regeneron Pharmaceuticals, Inc Retinal Biologics Basic Information
9.3.2 Regeneron Pharmaceuticals, Inc Retinal Biologics Product Overview
9.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Product Market Performance
9.3.4 Regeneron Pharmaceuticals, Inc Retinal Biologics SWOT Analysis
9.3.5 Regeneron Pharmaceuticals, Inc Business Overview
9.3.6 Regeneron Pharmaceuticals, Inc Recent Developments
9.4 AbbVie Inc
9.4.1 AbbVie Inc Retinal Biologics Basic Information
9.4.2 AbbVie Inc Retinal Biologics Product Overview
9.4.3 AbbVie Inc Retinal Biologics Product Market Performance
9.4.4 AbbVie Inc Business Overview
9.4.5 AbbVie Inc Recent Developments
9.5 Johnson and Johnson Services, Inc
9.5.1 Johnson and Johnson Services, Inc Retinal Biologics Basic Information
9.5.2 Johnson and Johnson Services, Inc Retinal Biologics Product Overview
9.5.3 Johnson and Johnson Services, Inc Retinal Biologics Product Market Performance
9.5.4 Johnson and Johnson Services, Inc Business Overview
9.5.5 Johnson and Johnson Services, Inc Recent Developments
9.6 Amgen Inc
9.6.1 Amgen Inc Retinal Biologics Basic Information
9.6.2 Amgen Inc Retinal Biologics Product Overview
9.6.3 Amgen Inc Retinal Biologics Product Market Performance
9.6.4 Amgen Inc Business Overview
9.6.5 Amgen Inc Recent Developments
10 Retinal Biologics Market Forecast by Region
10.1 Global Retinal Biologics Market Size Forecast
10.2 Global Retinal Biologics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Retinal Biologics Market Size Forecast by Country
10.2.3 Asia Pacific Retinal Biologics Market Size Forecast by Region
10.2.4 South America Retinal Biologics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Retinal Biologics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Retinal Biologics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Retinal Biologics by Type (2025-2030)
11.1.2 Global Retinal Biologics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Retinal Biologics by Type (2025-2030)
11.2 Global Retinal Biologics Market Forecast by Application (2025-2030)
11.2.1 Global Retinal Biologics Sales (K Units) Forecast by Application
11.2.2 Global Retinal Biologics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Retinal Biologics Market Size Comparison by Region (M USD)
Table 5. Global Retinal Biologics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Retinal Biologics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Retinal Biologics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Retinal Biologics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Table 10. Global Market Retinal Biologics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Retinal Biologics Sales Sites and Area Served
Table 12. Manufacturers Retinal Biologics Product Type
Table 13. Global Retinal Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Retinal Biologics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Retinal Biologics Market Challenges
Table 22. Global Retinal Biologics Sales by Type (K Units)
Table 23. Global Retinal Biologics Market Size by Type (M USD)
Table 24. Global Retinal Biologics Sales (K Units) by Type (2019-2024)
Table 25. Global Retinal Biologics Sales Market Share by Type (2019-2024)
Table 26. Global Retinal Biologics Market Size (M USD) by Type (2019-2024)
Table 27. Global Retinal Biologics Market Size Share by Type (2019-2024)
Table 28. Global Retinal Biologics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Retinal Biologics Sales (K Units) by Application
Table 30. Global Retinal Biologics Market Size by Application
Table 31. Global Retinal Biologics Sales by Application (2019-2024) & (K Units)
Table 32. Global Retinal Biologics Sales Market Share by Application (2019-2024)
Table 33. Global Retinal Biologics Sales by Application (2019-2024) & (M USD)
Table 34. Global Retinal Biologics Market Share by Application (2019-2024)
Table 35. Global Retinal Biologics Sales Growth Rate by Application (2019-2024)
Table 36. Global Retinal Biologics Sales by Region (2019-2024) & (K Units)
Table 37. Global Retinal Biologics Sales Market Share by Region (2019-2024)
Table 38. North America Retinal Biologics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Retinal Biologics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Retinal Biologics Sales by Region (2019-2024) & (K Units)
Table 41. South America Retinal Biologics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Retinal Biologics Sales by Region (2019-2024) & (K Units)
Table 43. Spark Therapeutics, Inc Retinal Biologics Basic Information
Table 44. Spark Therapeutics, Inc Retinal Biologics Product Overview
Table 45. Spark Therapeutics, Inc Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Spark Therapeutics, Inc Business Overview
Table 47. Spark Therapeutics, Inc Retinal Biologics SWOT Analysis
Table 48. Spark Therapeutics, Inc Recent Developments
Table 49. F. Hoffmann-La Roche Ltd Retinal Biologics Basic Information
Table 50. F. Hoffmann-La Roche Ltd Retinal Biologics Product Overview
Table 51. F. Hoffmann-La Roche Ltd Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. F. Hoffmann-La Roche Ltd Business Overview
Table 53. F. Hoffmann-La Roche Ltd Retinal Biologics SWOT Analysis
Table 54. F. Hoffmann-La Roche Ltd Recent Developments
Table 55. Regeneron Pharmaceuticals, Inc Retinal Biologics Basic Information
Table 56. Regeneron Pharmaceuticals, Inc Retinal Biologics Product Overview
Table 57. Regeneron Pharmaceuticals, Inc Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Regeneron Pharmaceuticals, Inc Retinal Biologics SWOT Analysis
Table 59. Regeneron Pharmaceuticals, Inc Business Overview
Table 60. Regeneron Pharmaceuticals, Inc Recent Developments
Table 61. AbbVie Inc Retinal Biologics Basic Information
Table 62. AbbVie Inc Retinal Biologics Product Overview
Table 63. AbbVie Inc Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AbbVie Inc Business Overview
Table 65. AbbVie Inc Recent Developments
Table 66. Johnson and Johnson Services, Inc Retinal Biologics Basic Information
Table 67. Johnson and Johnson Services, Inc Retinal Biologics Product Overview
Table 68. Johnson and Johnson Services, Inc Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Johnson and Johnson Services, Inc Business Overview
Table 70. Johnson and Johnson Services, Inc Recent Developments
Table 71. Amgen Inc Retinal Biologics Basic Information
Table 72. Amgen Inc Retinal Biologics Product Overview
Table 73. Amgen Inc Retinal Biologics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Amgen Inc Business Overview
Table 75. Amgen Inc Recent Developments
Table 76. Global Retinal Biologics Sales Forecast by Region (2025-2030) & (K Units)
Table 77. Global Retinal Biologics Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Retinal Biologics Sales Forecast by Country (2025-2030) & (K Units)
Table 79. North America Retinal Biologics Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Retinal Biologics Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Europe Retinal Biologics Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Retinal Biologics Sales Forecast by Region (2025-2030) & (K Units)
Table 83. Asia Pacific Retinal Biologics Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Retinal Biologics Sales Forecast by Country (2025-2030) & (K Units)
Table 85. South America Retinal Biologics Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Retinal Biologics Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Retinal Biologics Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Retinal Biologics Sales Forecast by Type (2025-2030) & (K Units)
Table 89. Global Retinal Biologics Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Retinal Biologics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 91. Global Retinal Biologics Sales (K Units) Forecast by Application (2025-2030)
Table 92. Global Retinal Biologics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Retinal Biologics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Retinal Biologics Market Size (M USD), 2019-2030
Figure 5. Global Retinal Biologics Market Size (M USD) (2019-2030)
Figure 6. Global Retinal Biologics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Retinal Biologics Market Size by Country (M USD)
Figure 11. Retinal Biologics Sales Share by Manufacturers in 2023
Figure 12. Global Retinal Biologics Revenue Share by Manufacturers in 2023
Figure 13. Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Retinal Biologics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Retinal Biologics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Retinal Biologics Market Share by Type
Figure 18. Sales Market Share of Retinal Biologics by Type (2019-2024)
Figure 19. Sales Market Share of Retinal Biologics by Type in 2023
Figure 20. Market Size Share of Retinal Biologics by Type (2019-2024)
Figure 21. Market Size Market Share of Retinal Biologics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Retinal Biologics Market Share by Application
Figure 24. Global Retinal Biologics Sales Market Share by Application (2019-2024)
Figure 25. Global Retinal Biologics Sales Market Share by Application in 2023
Figure 26. Global Retinal Biologics Market Share by Application (2019-2024)
Figure 27. Global Retinal Biologics Market Share by Application in 2023
Figure 28. Global Retinal Biologics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Retinal Biologics Sales Market Share by Region (2019-2024)
Figure 30. North America Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Retinal Biologics Sales Market Share by Country in 2023
Figure 32. U.S. Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Retinal Biologics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Retinal Biologics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Retinal Biologics Sales Market Share by Country in 2023
Figure 37. Germany Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Retinal Biologics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Retinal Biologics Sales Market Share by Region in 2023
Figure 44. China Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Retinal Biologics Sales and Growth Rate (K Units)
Figure 50. South America Retinal Biologics Sales Market Share by Country in 2023
Figure 51. Brazil Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Retinal Biologics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Retinal Biologics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Retinal Biologics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Retinal Biologics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Retinal Biologics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Retinal Biologics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Retinal Biologics Market Share Forecast by Type (2025-2030)
Figure 65. Global Retinal Biologics Sales Forecast by Application (2025-2030)
Figure 66. Global Retinal Biologics Market Share Forecast by Application (2025-2030)
